Flavonoids as Multi-Target Compounds: A Special Emphasis on their Potential as Chemo-adjuvants in Cancer Therapy.

Ajay G Namdeo, Sai H S Boddu, Haneen Amawi, Charles R Ashby, Diwakar B Tukaramrao, Piyush Trivedi, R Jayachandra Babu, Amit K Tiwari

Journal: Current pharmaceutical design 2020;26(15):1712-1728

PMID: 32003663

Abstract

Flavonoids are low molecular weight, polyphenolic phytochemicals, obtained from secondary metabolism of various plant compounds. They have a spectrum of pharmacological efficacies, including potential anticancer efficacy. Natural flavonoids are present in fruits, vegetables, grains, bark, roots, stems, flowers, tea and wine. Flavonoids can attenuate or inhibit the initiation, promotion and progression of cancer by modulating various enzymes and receptors in diverse pathways that involve cellular proliferation, differentiation, apoptosis, inflammation, angiogenesis and metastasis. Furthermore, in vitro, flavonoids have been shown to reverse multidrug resistance when used as chemo-adjuvants. Flavonoids (both natural and synthetic analogues) interact with several oncogenic targets through dependent and independent mechanisms to mediate their anticancer efficacy in different types of cancer cells.

Copyright© Bentham Science Publishers; For any queries, please email at [email protected].

Address: Poona College of Pharmacy, Bharati Vidyapeeth Deemed University, Pune, India.; College of Pharmacy and Health Sciences, Ajman University, Ajman, United Arab Emirates.; Department of Pharmacy practice, Faculty of Pharmacy, Yarmouk University, P.O. BOX 566, Irbid 21163, Jordan.; Department of Pharmaceutical Sciences, St. John's University, Queens, NY 11439, United States.; Department of Pharmacology and Experimental Therapeutics, The University of Toledo, Toledo, OH 43606, United States.; Department of Drug Discovery and Development, Auburn University, Auburn, AL 36849, United States.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.